Skip to main content

Advertisement

SpringerLink
Log in

Reversible posterior leucoencephalopathy during oral treatment with methotrexate

  • LETTER TO THE EDITORS
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Neurology Department, University Hospital Gasthuisberg, Leuven, Belgium

    Dimitri Renard MD, Erik Vandenbussche PhD & Rik Vandenberghe MD, PhD

  2. Department of Rheumatology, University Hospital Gasthuisberg, Leuven, Belgium

    Rene Westhovens MD, PhD

Authors
  1. Dimitri Renard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rene Westhovens MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erik Vandenbussche PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rik Vandenberghe MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rik Vandenberghe MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Renard, D., Westhovens, R., Vandenbussche, E. et al. Reversible posterior leucoencephalopathy during oral treatment with methotrexate. J Neurol 251, 226–228 (2004). https://doi.org/10.1007/s00415-004-0287-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-004-0287-5

Keywords

Search

Navigation